Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Cancer Res. 2010 Sep 16;70(21):8446–8456. doi: 10.1158/0008-5472.CAN-10-1590

Table 1.

p23 Expression in Relation to Stage and TMN from the Breast Tumor Microarray

Samples (N=213) Cytoplasm P23
P-Value (Tests 1+&2+ vs. 3+)
1+ (N=2) 2+ (N=22) 3+ (N=189)

Age mean±SD 46.0±42.24 50.91±10.27 55.12±13.21 0.10*

Nuclear p23 0 2 (100%) 4 (18%) 2 (1%) <0.0001**
1+ 0 10 (45%) 33 (17%)
2+ 0 7 (32%) 69 (37%)
3+ 0 1 (5%) 85 (45%)

Stage I 0 3 (14%) 5 (3%) <0.01**
II 1 (50%) 11 (50%) 55 (29%)
III 1 (50%) 8 (36%) 108 (57%)
IV 0 0 21 (11%)

T 1 0 3 (14%) 7 (4%) 0.09**
2 1 (50%) 9 (43%) 54 (31%)
3 1 (50%) 3 (14%) 30 (17%)
4 0 6 (29%) 81 (47%)
missing 1 17

N 0 1 (50%) 13 (59%) 50 (27%) <0.01***
1 1 (50%) 6 (27%) 46 (24%)
2 0 3 (14%) 52 (28%)
3 0 0 40 (21%)
missing 1

M 0 2 (100%) 22 (100%) 168 (89%) 0.14**
1 0 0 21 (11%)
*

T-Test,

**

-Fisher Exact Test,

***

-Chi-Square Test